Please login to the form below

brentuximab vedotin

This page shows the latest brentuximab vedotin news and features for those working in and with pharma, biotech and healthcare.

AZ nabs US approval for new leukaemia drug Lumoxiti

Seattle Genetics/Takeda’ s classical Hodgkin lymphoma therapy Adcetris (brentuximab vedotin) and Roche’s Kadcyla (trastuzumab emtansine) for breast cancer.

Latest news

Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE

England’s cost effectiveness watchdog says there are limited treatment options for people who have not responded to, or only have a temporary response to, brentuximab vedotin and cannot have stem
Seattle Genetics claims key US approval for Adcetris

Adcetris (brentuximab vedotin), an antibody-drug conjugate, is the first new treatment for this type of lymphoma in more than 40 years, with the US regulator approving it for use alongside ... Seattle has since turned its attention to its own TNBC
Takeda bags EU approval for Adcetris in lymphoma

CTCL). Adcetris (brentuximab vedotin) - a CD30-targeting antibody drug conjugate (ADC) - already has conditional approval in the EU for certain adult patients with relapsed or refractory CD30-positive Hodgkin lymphoma, but
Seattle Genetics' Adcetris earns FDA priority review status

Adcetris (brentuximab vedotin), an antibody-drug conjugate, was awarded the status based on the results of the phase III ECHELON-1 trial, which had a primary endpoint of an improved PFS
NICE reverses stance on Takeda’s Adcetris

Takeda has claimed a partial win for its non-Hodgkin’s lymphoma drug Adcetris (brentuximab vedotin) after persuading NICE to change its mind and issue new draft guidance. ... I am delighted that patients can maintain long term access to Brentuximab

More from news
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Interview: Trevor Smith, Takeda

Even closer to market is Takeda's monoclonal antibody treatment for Hodgkin's Lymphoma, Adcetris (brentuximab vedotin), which was recommended for European approval in July and which Takeda expects to launch

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Healthcare Advertising Agency: Salary TBC

Account Director or Senior Account Director: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Healthcare PR Director: £100, 000 – £120, 000 benefits

Account Manager: Negotiable

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Account Manager – Healthcare Advertising: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Systematic Review Lead- London: Negotiable

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Subscribe to our email news alerts

PMHub

Add my company

Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...